Macleods Pharmaceuticals has initiated a voluntary US-wide recall of more than 3,700 bottles of blood pressure medication due to "failed dissolution specifications."
Issued on October 7, the recall is due to the fact that the drug may not release its active ingredients at the proper rate once inside the body, potentially reducing its effectiveness in lowering blood pressure as expected.
More recently, on October 26, the FDA rated the recall a Class II, meaning the use of the medication may cause temporary or medically reversible health consequences but is unlikely to cause serious health problems.
So far, the FDA has not issued a news release for this recall. However, letters were sent to customers who may have purchased the medications, according to its enforcement report. Those who have bought the medication are advised to speak to their healthcare provider regarding its continued use.
The popular brand name of the drug is Tribenzor. Overall, 3,528 of the 30-count bottles and 216 of the 90-count bottles were recalled.
Indeed, product recalls occur when manufacturers or regulators identify defects or safety concerns that could put consumers at risk. Some cases have become major public health concerns, prompting nationwide action. Intrigued? Read through to discover the products that have fallen victim to a total recall.